Alpro Group and AstraZeneca Collaborate to Advance Early Detection Across the Cardio-Kidney-Metabolic Spectrum and Raise Awareness of Hyperkalemia

Nationwide #AreYourKidneysOK+? initiative expands access to subsidised blood screening, public education, and pharmacist support for 12,550 Malaysians.

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 19 August 2026 – As chronic conditions such as diabetes, cardiovascular disease and chronic kidney disease continue to affect Malaysians, early detection is becoming increasingly important in reducing complications and improving long-term health outcomes.

(From left: Dr. Cheng Yong Fatt (Consultant Nephrologist of KPJ Seremban Specialist Hospital); Dr. Svetlana Yanchuk (Country President of AstraZeneca Malaysia); Ph. Hiew Fei Tsong (Co-founder of Alpro Group); Dr. Ng Ming Lee (Medical Director of Alpro Clinic); Ms Jenny Poon (Business Unit Director of CVRM/R&I of AstraZeneca Malaysia); Dr. Yong Lit Sin (Consultant Endocrinologist of Columbia Asia Hospital Seremban)

These conditions are closely interconnected across the Cardio-Kidney-Metabolic spectrum, meaning that a problem affecting one area of health may also increase the risks to other parts of the body. However, many individuals may not recognise these risks until their condition has progressed or complications have developed.

One such complication is hyperkalemia, a condition characterised by elevated potassium levels in the blood. Hyperkalemia is more common among people living with chronic kidney disease because impaired kidneys may have lower ability to remove excess potassium from the body. As the condition may not always present noticeable warning signs, it remains under-recognised by the public and may lead to serious complications affecting the heart's rhythm if not appropriately identified and managed.

Recognising the need to strengthen early detection and public awareness across the Cardio-Kidney-Metabolic (CKM) spectrum, Alpro Group, in collaboration with AstraZeneca Malaysia, announced the launch of #AreYourKidneysOK+?, a nationwide awareness campaign dedicated to encourage early detection, promoting kidney health, and raising awareness of hyperkalemia.

This nationwide initiative aims to empower Malaysians to better understand the connection between their heart, kidney and metabolic health, while bringing greater attention to hyperkalemia as an often-overlooked complication associated with chronic kidney disease.

At the heart of the campaign is a subsidised blood screening programme aimed at encouraging more Malaysians to take an earlier and more proactive approach to their health. Eligible individuals will receive subsidy on selected blood test packages, to reduce financial barriers in screening and to support the earlier identification of potential Cardio-Kidney-Metabolic and health risks.

The campaign aims to reach 12,550 individuals across Malaysia, a shared commitment by Alpro Group and AstraZeneca Malaysia to turn public health awareness into meaningful action.

Beyond providing financial support for screening, the campaign creates a more accessible pathway for Malaysians to learn about their potential health risks, undergo appropriate screening and speak to their healthcare professionals about the next steps they may need to undertake.

To extend the campaign's reach beyond physical pharmacy locations, the initiative is supported by a dedicated digital health education platform containing trusted and easy-to-understand information about hyperkalemia, including its causes, risk factors, possible warning signs and relationship with chronic kidney disease.

The platform serves as a public health resource that Malaysians can access at any time, helping individuals and caregivers better understand hyperkalemia and prepare for more informed conversations with pharmacists, doctors and other healthcare professionals.

Through Alpro Group's community healthcare network, members of the public will also have greater access to pharmacist support and guidance. Alpro pharmacists can help individuals better understand the importance of screening, recognise relevant risk factors and seek appropriate medical assessment or follow-up when necessary.

"Many chronic health risks develop quietly and may only be discovered after complications have occurred. Through this campaign, we want to make preventive healthcare more accessible by connecting public education, affordable screening and professional healthcare support. By targeting 12,550 Malaysians, we hope to encourage more people to take an earlier and more proactive step towards understanding their heart, kidney and metabolic health," said Dr. Ng Ming Lee, Medical Director of Alpro Clinic.

"As chronic kidney disease remains a significant public health challenge in Malaysia, this collaboration reflects a shared commitment across the healthcare ecosystem to strengthen public awareness of kidney health and bring health education closer to the public. Through Alpro Group's nationwide network, we aim to help more Malaysians learn about relevant risk factors and have informed conversations with healthcare professionals to support appropriate assessment and follow-up," said Dr. Svetlana Yanchuk, Country President, AstraZeneca Malaysia.

Through this collaboration, Alpro Group and AstraZeneca Malaysia reaffirm their shared commitment to advancing preventive healthcare by combining greater public awareness, accessible screening and professional healthcare support.

The campaign also demonstrates the important role that community pharmacies can play in supporting wider public health efforts by providing Malaysians with convenient access to health education, early screening opportunities and trusted professional guidance within their communities.

Members of the public are encouraged to learn more about hyperkalemia by visiting www.alpropharmacy.com/pages/hyperkalemia or by speaking to an Alpro pharmacist.

References
1. KDIGO Controversies Conference. Potassium Homeostasis and Management of Dyskalemia in Kidney Diseases. Kidney International (2020). [kdigo.org]

2. National Kidney Foundation. High Potassium (Hyperkalemia): Causes, Symptoms, and Treatment (updated 2025).
Hashtag: #AlproPharmacy #AlproGroup #AreYourKidneysOK+?

The issuer is solely responsible for the content of this announcement.

About Alpro Group

Founded in 2002, Alpro Group's ecosystem has grown to include Alpro Pharmacy, Apotek Alpro, Alpro スギ (Sugi) Pharmacy, Alpro Physio, Alpro Clinic, Alpro Baby, Alpro OptiSaver, Alpro Audiology, Alpro Health, and Alpro Foundation. Supported by a team of more than 1,000 healthcare professionals, including doctors, pharmacists, nutritionists, dietitians, physiotherapists, optometrist and many others, Alpro serves over 5 million families in Malaysia and Indonesia through its extensive network of 500 physical outlets.

Alpro Pharmacy is the first and only community pharmacy in the region to offer product liability insurance of MYR 1 million in Malaysia and IDR 3 billion in Indonesia, ensuring the supply of genuine medications and enhancing consumer trust.

With the vision of a healthy and vibrant world, Alpro Group aims to become the No. 1 prescription pharmacy chain in Southeast Asia.

About AstraZeneca

AstraZeneca is a global, science led biopharmaceutical company focused on the discovery, development, and commercialisation of innovative medicines that transform patient outcomes. Headquartered in Cambridge, United Kingdom, the company operates in more than 100 countries and plays a significant role in advancing modern healthcare through research driven innovation and strategic partnerships worldwide.

Guided by its purpose to push the boundaries of science to deliver life changing medicines, AstraZeneca prioritises long term investment in research and development. The company's global strategy is built on deep scientific expertise, advanced technology platforms, and precision medicine approaches, including biologics, antibody drug conjugates, and data driven drug discovery. These capabilities enable AstraZeneca to address complex diseases and unmet medical needs with increasing accuracy and effectiveness.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

The transaction follows the landmark property’s March 2026 debut and marks the completion of the joint venture transformation of the Lake Como site into a five-star EDITION hotel

BANGKOK, THAILAND – Media OutReach Newswire – 9 September 2026 – Bain Capital, a leading global private investment firm, and Omnam Group, a Europe-based hospitality real estate developer and investor, recently announced the sale of The Lake Como EDITION to Sansiri Capital, the hospitality trophy asset fund of Sansiri Public Company Limited, a leading Thai real estate developer with more than 40 years of experience. The transaction marks the culmination of the partners' transformation of the landmark Lake Como property into one of Italy's most significant new luxury hospitality destinations. The transaction is expected to be completed in the next several weeks. Completion remains subject to customary closing conditions and required third-party approvals. Financial terms were not disclosed.

Set on the shores of Cadenabbia, the property occupies a rare waterfront position opposite Bellagio, with access to Milan and Malpensa International Airport in approximately one hour. The landmark 19th-century palazzo was acquired by Bain Capital and Omnam Group in late 2021. An extensive redevelopment began in April 2022, reimagining the historic property as The Lake Como EDITION. The hotel opened in March 2026, just under six months ago, as part of Marriott International's EDITION Hotels portfolio, introducing a new expression of contemporary luxury to one of Italy's most iconic destinations.

At acquisition, Bain Capital and Omnam identified an opportunity to create a new luxury hospitality offering in a market characterized by strong international demand, limited five-star supply and significant barriers to new lakeside development. Acquiring the property with vacant possession enabled the partners to undertake a comprehensive repositioning rather than an incremental refurbishment.

The sale reflects growing international investor interest in distinctive, experience-led European hospitality assets and marks Sansiri's strategic expansion into Europe's luxury hospitality sector through the Sansiri Capital fund, further strengthening its portfolio of trophy assets. For Bain Capital and Omnam Group, the transaction demonstrates the value created by combining real estate investment, development expertise and leading hospitality partners to reposition a complex asset.

The redevelopment substantially reconfigured the property, reducing the former hotel's room count from nearly 300 to 148 larger rooms and suites and creating a new spa and wellness building, alongside an extensive food and beverage and leisure offering. The transformation also incorporated the property's distinctive waterfront amenities, including its floating pool and beach club.

Ali Haroon, a Partner and Head of Europe Real Estate for Bain Capital, said:

"Lake Como is a strong example of how we approach real estate investing in Europe. We focus on sectors supported by long-term structural demand and opportunities where our capital, local relationships and hands-on capabilities can fundamentally transform an asset. Together with Omnam, we have taken a highly underinvested property in an irreplaceable location and created a contemporary luxury destination for the international market. This is exactly the type of complex, execution-led opportunity we seek across our Europe Real Estate strategy."

David Zisser, CEO and Founder of Omnam Group, said:

"The Lake Como EDITION has been an ambitious undertaking from the outset. Our vision was to take a remarkable historic property in one of the world's most iconic destinations and give it new relevance through architecture, design and hospitality, while remaining deeply connected to the character of Lake Como.

Together with Bain Capital and an exceptional group of partners, we have taken that vision from acquisition and development through to the opening of a landmark new hotel. We are immensely proud of what has been created. The completion of this transaction is a significant milestone for Omnam and a testament to the strength of our development approach, while marking the beginning of an exciting new chapter for The Lake Como EDITION."

The sale of The Lake Como EDITION marks the latest chapter in Omnam Group's expanding presence across Europe, where an ambitious pipeline of projects is currently underway in Florence, Venice, Puglia and Sicily — each reimagining distinctive properties into internationally relevant lifestyle destinations.

The acquisition also marks a significant international investment for Sansiri Public Company Limited, bringing one of Lake Como's newest luxury hospitality assets into its trophy-asset portfolio through Sansiri Capital, the hospitality trophy-asset investment arm.

Napat Thavisin, President of International Operations, Sansiri Public Company Limited and Managing Director of Sansiri Capital, said:

"The acquisition of The Lake Como EDITION marks a significant milestone in advancing Sansiri's New S-Curve strategy. It strengthens our financial resilience and diversifies risk across our global hospitality portfolio. We remain focused on ultra-luxury trophy assets in gateway cities and high-demand leisure destinations—markets characterised by robust demand and inherently constrained supply. This disciplined capital-allocation approach is designed to maximise long-term shareholder value.

As Thailand's No.1 most trusted luxury real estate developer, with 40 year of experience, Sansiri brings a proven record in global markets from The Manner SoHo, New York to the growth of Standard International prior to its acquisition by Hyatt Hotels Corporation. Leveraging this expertise, we look forward to stewarding this exceptional investment in The Lake Como EDITION under Sansiri Capital's ownership, in collaboration with Marriott International, which will continue to operate the hotel, while further diversifying our revenue streams across major global currencies. Looking ahead, Sansiri will actively pursue trophy-asset investments in premier leisure and gateway destinations worldwide, reinforcing our position as a fully integrated global real estate and lifestyle investment platform."

Hashtag: #Sansiri

The issuer is solely responsible for the content of this announcement.

** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **

The Lake Como EDITION

Penthouse

The Pool

The Lake Como EDITION